Author(s):
Bibendu Bal, Aparajita Mishra, Atanu Kumar Bal, Devidutta Ramani Ranjan Rout, Sashibhusan Dash
Email(s):
Author Email:
DOI:
10.52711/0974-360X.2025.00794 
Address:
Bibendu Bal1, Aparajita Mishra2, Atanu Kumar Bal3, Devidutta Ramani Ranjan Rout4, Sashibhusan Dash5
1Senior Resident, Department of Pathology, PRM Medical College and Hospital, Baripada, Odisha, India.
2Associate Professor, Department of Pathology, Government Medical College and Hospital, Sundargarh, Odisha, India.
3Associate Professor, Department of Pathology, PRM Medical College and Hospital, Baripada,Odisha,India.
4Senior Resident, Department of Pathology, PRM Medical College and Hospital, Baripada, Odisha, India.
5 Scientist C, Multi Disciplinary Research Unit, PRM. Medical College and Hospital, Baripada, Odisha, India.
Corresponding Author
Published In:
Volume - 18,
Issue - 11,
Year - 2025
ABSTRACT:
The Paris System aims to create consistent guidelines for reporting urinary tract cytology results. This study evaluated how well these guidelines work and compared them to the outcomes of follow-up biopsies. A total 70 patient were included in this study out of which 80% were male. Most common age of presentation of urinary bladder lesions was between 61-80 years (55.7%).Most common lesion by urinary cyto-diagnosis according to TPS was found to be HGUC 30 (42.9%) followed by NHGUC 15 (21.4%). The sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy of the Paris system for urine cytology in assessing urinary bladder neoplasm was 79%,70.9%,83.3%,65.4% ,74.3% respectively.TPS standardizes urine cytology criteria, boosting accuracy and reducing equivocal diagnoses (like atypical urothelial cells). This facilitates high-grade urothelial carcinoma (HGUC) detection.
Cite this article:
Bibendu Bal, Aparajita Mishra, Atanu Kumar Bal, Devidutta Ramani Ranjan Rout, Sashibhusan Dash. The Paris System for Urine Cytology in Urothelial Neoplasms: A Comparative Study with Histopathological Correlation. Research Journal Pharmacy and Technology. 2025;18(11):5509-4. doi: 10.52711/0974-360X.2025.00794
Cite(Electronic):
Bibendu Bal, Aparajita Mishra, Atanu Kumar Bal, Devidutta Ramani Ranjan Rout, Sashibhusan Dash. The Paris System for Urine Cytology in Urothelial Neoplasms: A Comparative Study with Histopathological Correlation. Research Journal Pharmacy and Technology. 2025;18(11):5509-4. doi: 10.52711/0974-360X.2025.00794 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2025-18-11-56
REFERENCES:
1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2): 69-90. doi: 10.3322/caac.20107.
2. Sullivan PS, Chan JB, Levin MR, Rao J. Urine cytology and adjunct markers for detection and surveillance of bladder cancer. Am J Transl Res. 2010; 2(4): 412-40. https://pubmed.ncbi.nlm.nih.gov/20733951/
3. Chao D, Freedland SJ, Pantuck AJ, Zisman A, Belldegrun AS. Bladder cancer 2000: molecular markers for the diagnosis of transitional cell carcinoma. Rev Urol. 2001 Spring; 3(2):85-93. https://pubmed.ncbi.nlm.nih.gov/16985695/
4. Hughes JH, Raab SS, Cohen MB. The cytologic diagnosis of low-grade transitional cell carcinoma. Am J Clin Pathol. 2000 Nov; 114 Suppl: S59-67. doi: 10.1093/ppr/114.1.s59.
5. Rosenthal DL, Wojcik EM, Kurtycz Daniel EI. The Paris System for Reporting Urinary Cytology 2016 New York Springer
6. Barkan GA, Wojcik EM, Nayar R, Savic-Prince S, Quek ML, Kurtycz DF, et al. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology. Acta Cytol. 2016;60(3):185-97. doi: 10.1159/000446270.
7. Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Compérat E, et al. European Association of Urology. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013 Oct; 64(4): 639-53. doi: 10.1016/j.eururo.2013.06.003.
8. Raisi O, Magnani C, Bigiani N, Cianciavicchia E, D'Amico R, Muscatello U, et al. The diagnostic reliability of urinary cytology: a retrospective study. Diagn Cytopathol. 2012 Jul; 40(7): 608-14. doi: 10.1002/dc.21716.
9. Granados R, Butrón M, Santonja C, Rodríguez JM, Martín A, Duarte J, et al. Increased risk of malignancy for non-atypical urothelial cell groups compared to negative cytology in voided urine. Morphological changes with LBC. Diagn Cytopathol. 2016 Jul; 44(7): 582-90. doi: 10.1002/dc.23489.
10. Rosai and Ackerman’s surgical pathology,11th edition.
11. Wang Y, Auger M, Kanber Y, Caglar D, Brimo F. Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the "atypical" category and an increase in its prediction of subsequent high-grade urothelial carcinoma. Cancer Cytopathol. 2018 Mar; 126(3): 207-214. doi: 10.1002/cncy.21958.
12. Malviya K, Fernandes G, Naik L, Kothari K, Agnihotri M. Utility of the Paris System in Reporting Urine Cytology. Acta Cytol. 2017; 61(2): 145-152. doi: 10.1159/000464270.
13. Meilleroux J, Daniel G, Aziza J, d'Aure DM, Quintyn-Ranty ML, Basset CM, et al. One year of experience using the Paris System for Reporting Urinary Cytology. Cancer Cytopathol. 2018 Jun; 126(6): 430-436. doi: 10.1002/cncy.21999.
14. Mitra AP, Cote RJ. Molecular screening for bladder cancer: progress and potential. Nat Rev Urol. 2010 Jan; 7(1): 11-20. doi: 10.1038/nrurol.2009.236.
15. Zheng X, Si Q, Du D, Harshan M, Zhang Z, Haines K, et al. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection. Cytopathology. 2018 Apr; 29(2): 184-188. doi: 10.1111/cyt.12505.
16. Das S, Chowdhury AR, Basu S, Lath A. A Study on Association of Urine Cytology as Reported by the Paris System with Histopathology and p53 Expression in Urinary Bladder Epithelial Neoplasms.J Clin of Diagn Res. 2019; 13(10): EC04-EC09. https://www.doi.org/10.7860/JCDR/2019/42014/13201
17. Stanzione N, Ahmed T, Fung PC, Cai D, Lu DY, Sumida LC, et al. The continual impact of the Paris System on urine cytology, a 3-year experience. Cytopathology. 2020 Jan; 31(1): 35-40. doi: 10.1111/cyt.12777.
18. Nabi G, Greene DR, O'Donnell M. How important is urinary cytology in the diagnosis of urological malignancies? Eur Urol. 2003 Jun; 43(6): 632-6. doi: 10.1016/s0302-2838(03)00147-7.
19. Robbins and Cotran Pathological Basic of Disease, 10th edition.
20. Roy M, Kaushal S, Jain D, Seth A, Iyer VK, Mathur SR. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology. Cytopathology. 2017 Dec; 28(6): 509-515. doi: 10.1111/cyt.12448.